Stents Market Introduction and Overview
According to SPER Market Research, the Global Stents Market is estimated to reach USD 21.68 billion by 2034 with a CAGR of 3.95%.
The rising incidence of coronary artery disease, improvements in stent technology, and increased spending on healthcare and research development by both public and private entities are the main factors propelling the growth of the worldwide stents market. The market is growing as a result of the need for drug-eluting stents. One of the most prevalent heart diseases, coronary artery disease has a significant death rate, which highlights the need for efficient treatment options. The market is expanding because to the increased availability of percutaneous coronary intervention (PCI) procedures and technological advancements in medical infrastructure. The market for stents is also anticipated to rise as a result of the increasing number of medication approvals. However, during the projection period, the market's growth may be constrained by the high cost of stent treatments.
By Product: Based on the product, the coronary stents segment led the stents market in 2020. This trend is anticipated to persist throughout the forecast period due to the rise in the prevalence of coronary artery disease, technological advancements in the biotechnology and pharmaceutical industries, and the increased use of drug-eluting stents. However, due to the rising incidence of peripheral artery disease and the expansion of major stent manufacturing companies, the peripheral stents market is anticipated to develop significantly over the course of the projected period.
By Material: Based on material, in 2020, the metallic materials segment led the stents market, and this trend is expected to continue during the forecast period. The dominance of this segment is driven by the increasing prevalence of cardiovascular diseases, the growing number of key players manufacturing metallic stents, and the rise in surgical procedures like fluoroscopy and endoscopy. However, the polymeric biomaterials segment is projected to experience significant growth in the coming years. This growth is attributed to the rising prevalence of cardiovascular diseases, increased focus by companies on developing and producing polymeric stents, and a greater number of government approvals for the development of polymer-based stents.
By End Use: The hospital segment led the stents market in 2020 and is anticipated to continue to do so throughout the forecast period. This is brought on by the rising incidence of coronary artery diseases, government programs to improve healthcare facilities, heightened knowledge on how to treat and manage illnesses, and the trend toward more sedentary lifestyles. However, due to the growing demand for angioplasty treatments and improvements in healthcare technology, the ambulatory surgery centers market is anticipated to rise significantly over the next several years.
By Region: North America dominated the stents market in 2020 and is anticipated to continue to do so for the duration of the projection. The increasing incidence of cardiovascular disorders, the rise in stent product approvals, the development of healthcare infrastructure, the presence of major stent manufacturers, and technological improvements in the healthcare industry in the region are all responsible for this. But throughout the course of the forecast period, the Asia-Pacific area is expected to expand at the fastest rate due to factors like rising healthcare costs, a shift toward unhealthy lifestyles, an aging population, and the incidence of coronary heart disease.
Recent Developments:
- Abbott introduced the XIENCE Sierra, a novel coronary stent system intended to treat artery blockages, in India in May 2024. For complicated cardiac conditions, this XIENCE family addition provides enhanced safety. Abbott's inventions have continuously improved the field of angioplasty, which is a technique to open blocked or constricted arteries.
- Leading coronary stent supplier Translumina Therapeutics began operations in the United Arab Emirates in September 2024. Advanced drug-eluting stent technologies, such as the most researched DES in the world, have been developed through their partnership with the prestigious German Heart Center and supported by more than 10 years of safety and effectiveness studies.
Market Competitive Landscape:
The Global Stents Market is highly consolidated. Some of the market players are Abbott Laboratories, B. Braun Melsungen AG, BD, Biosensors International Group, Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, Elixir Medical Corporation, Medtronic Plc, Meril Life Science, MicroPort Scientific Corporation, Stryker, Terumo Corporation, W.L Gore & Associates, and Others.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Product, By Material, By End Use. |
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe. |
| Companies Covered | Abbott Laboratories, B. Braun Melsungen AG, BD, Biosensors International Group, Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, Elixir Medical Corporation, Medtronic Plc, Meril Life Science, MicroPort Scientific Corporation, Stryker, Terumo Corporation, W.L Gore & Associates, and Others. |
Key Topics Covered in the Report:
- Global Stents Market Size (FY’2021-FY’2034)
- Overview of Global Stents Market
- Segmentation of Global Stents Market By Product (Coronary Stents, Peripheral Stents, Stent Related Implant)
- Segmentation of Global Stents Market By Material (Metallic Biomaterial, Polymer Biomaterial, Natural Biomaterial)
- Segmentation of Global Stents Market By End Use (Hospital, Ambulatory Surgical Centers, Others)
- Statistical Snap of Global Stents Market
- Expansion Analysis of Global Stents Market
- Problems and Obstacles in Global Stents Market
- Competitive Landscape in the Global Stents Market
- Details on Current Investment in Global Stents Market
- Competitive Analysis of Global Stents Market
- Prominent Players in the Global Stents Market
- SWOT Analysis of Global Stents Market
- Global Stents Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Stents Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Stents Market
7. Global Stents Market, By Product (USD Million) 2021-2034
7.1. Coronary Stents
7.1.1. Drug-eluting stents (DES)
7.1.2. Bare-metal coronary stents
7.1.3. Bioabsorbable stents
7.2. Peripheral Stents
7.2.1. Iliac stent
7.2.2. Femoral-popliteal stents
7.2.3. Renal & related stents
7.2.4. Carotid stents
7.3. Stent Related Implant
7.3.1. Synthetic grafts
7.3.2. Vena cava filters
8. Global Stents Market, By Material (USD Million) 2021-2034
8.1. Metallic Biomaterial
8.2. Polymer Biomaterial
8.3. Natural Biomaterial
9. Global Stents Market, By End User (USD Million) 2021-2034
9.1. Hospital
9.2. Ambulatory Surgical Centers
9.3. Others
10. Global Stents Market (USD Million) 2021-2034
10.1. Global Stents Market Size and Market Share
11. Global Stents Market, By Region, (USD Million) 2021-2034
11.1. Asia-Pacific
11.1.1. Australia
11.1.2. China
11.1.3. India
11.1.4. Japan
11.1.5. South Korea
11.1.6. Rest of Asia-Pacific
11.2. Europe
11.2.1. France
11.2.2. Germany
11.2.3. Italy
11.2.4. Spain
11.2.5. United Kingdom
11.2.6. Rest of Europe
11.3. Middle East and Africa
11.3.1. Kingdom of Saudi Arabia
11.3.2. United Arab Emirates
11.3.3. Qatar
11.3.4. South Africa
11.3.5. Egypt
11.3.6. Morocco
11.3.7. Nigeria
11.3.8. Rest of Middle-East and Africa
11.4. North America
11.4.1. Canada
11.4.2. Mexico
11.4.3. United States
11.5. Latin America
11.5.1. Argentina
11.5.2. Brazil
11.5.3. Rest of Latin America
12. Company Profile
12.1. Abbott Laboratories
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. B. Braun Melsungen AG
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. BD
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. Biosensors International Group, Ltd.
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. Biotronik SE & Co. KG
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. Boston Scientific Corporation
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Elixir Medical Corporation
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Medtronic Plc
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. Meril Life Science
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. MicroPort Scientific Corporation
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11. Stryker
12.11.1. Company details
12.11.2. Financial outlook
12.11.3. Product summary
12.11.4. Recent developments
12.12. Terumo Corporation
12.12.1. Company details
12.12.2. Financial outlook
12.12.3. Product summary
12.12.4. Recent developments
12.13. W.L Gore & Associates
12.13.1. Company details
12.13.2. Financial outlook
12.13.3. Product summary
12.13.4. Recent developments
12.14. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links